secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK:        0001281895
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001140361-25-022996
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rocket Pharma annual meeting: all director nominees elected, auditor ratified, say-on-pay approved
--------------------------------------------------------------------------------

- 10 director nominees elected; David P. Southwell received 55.4M for vs 23.8M withheld, still elected on plurality standard.
- Ratification of EisnerAmper as auditor approved with 90.7M votes for, 141.8K against, 528.3K abstentions.
- Non-binding advisory vote on executive compensation passed with 77.2M for, 1.4M against, 515K abstentions.
- Turnout of 91.4M shares (85.56% of eligible) voted at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1281895/000114036125022996/0001140361-25-022996-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1281895/000114036125022996/ef20050794_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-022996

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer